Selecting the Right Model Before Target Animal Studies
Model selection is not simply about choosing an available model. It should be designed backward from the development question, disease biology, candidate MoA, endpoints, biomarkers, and Go / No-Go criteria.
In Animal Health development, dog and cat studies may ultimately become important. However, target animal studies can be costly, variable, and difficult to interpret if the team has not clarified what should be evaluated before entering that stage.
KGAH-ONE focuses on structuring the full evaluation logic before target animal studies. The model, endpoints, biomarkers, pathology analysis, dosing timing, and decision criteria should work together so that the next study becomes more interpretable.
Scientific Question
Are you selecting a model because it is available, or because it answers the development question that matters?
One-line Answer
Model selection is a development-design question that connects disease biology, candidate profile, endpoints, biomarkers, and Go / No-Go decisions.
Common failure patterns
Choosing a model because it exists
If the model comes before the development question, the result may be difficult to interpret.
Adding endpoints too late
If endpoints are not designed upfront, the study may miss information needed for the next decision.
Not knowing why it failed
Without pathology, biomarkers, or MoA readouts, a negative result may not generate useful learning.
No bridge to target animal studies
The team may be left unclear about what to carry forward into dog or cat studies.
Model Selection Framework
- Which disease biology should the model reflect?
- What is the candidate target / MoA?
- Does the model fit the modality?
- What are the primary and secondary endpoints?
- Is the timing preventive, therapeutic, or disease-modifying?
- Which biomarkers should be carried into target animal studies?
- Which readouts will support Go / No-Go decisions?
- What can the team learn if the study succeeds or fails?
Four connections to consider
The role of KGAH-ONE
KGAH-ONE is not positioned as a simple model-sales channel. We help Animal Health developers organize the development question, nonclinical evaluation strategy, model selection, endpoint design, pathology and biomarker evaluation, and expert partner coordination.
The goal is to clarify what should be learned before target animal studies, so that the next study becomes more meaningful and interpretable.
It is to understand the candidate’s potential and limitations before target animal studies and improve the quality of the next decision.
Clarify your model selection strategy before target animal studies
KGAH-ONE helps organize model selection, endpoints, pathology and biomarker evaluation, and expert partner coordination based on your disease area, candidate profile, and development question.